MicrobeWorld

A sensitive new diagnostic test for methicillin-resistant Staphylococcus aureus (MRSA)--a drug-resistant bacterium that can run rampant in hospitals--could help broaden access to fast, cheap testing. The test, being developed by Adnavance Technologies, a startup in San Diego, is simpler to perform than existing molecular diagnostics, potentially making it accessible to hospitals without sophisticated labs.